Castleark Management LLC Sells 1,150 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Castleark Management LLC reduced its position in Axon Enterprise, Inc. (NASDAQ:AXON) by 29.3% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 2,770 shares of the biotechnology company’s stock after selling 1,150 shares during the quarter. Castleark Management LLC’s holdings in Axon Enterprise were worth $1,107,000 as of its most recent filing with the SEC.

Several other large investors also recently modified their holdings of the company. Public Sector Pension Investment Board boosted its position in Axon Enterprise by 19.2% during the third quarter. Public Sector Pension Investment Board now owns 3,104 shares of the biotechnology company’s stock valued at $1,240,000 after acquiring an additional 500 shares during the last quarter. CIBC Asset Management Inc raised its position in shares of Axon Enterprise by 9.2% in the 3rd quarter. CIBC Asset Management Inc now owns 10,578 shares of the biotechnology company’s stock worth $4,227,000 after acquiring an additional 895 shares in the last quarter. Foundations Investment Advisors LLC acquired a new position in shares of Axon Enterprise in the 3rd quarter valued at about $221,000. Sequoia Financial Advisors LLC boosted its position in shares of Axon Enterprise by 4.9% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 1,727 shares of the biotechnology company’s stock valued at $690,000 after purchasing an additional 81 shares in the last quarter. Finally, Axxcess Wealth Management LLC acquired a new stake in Axon Enterprise during the third quarter worth approximately $814,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Axon Enterprise

In other Axon Enterprise news, CEO Patrick W. Smith sold 47,314 shares of the stock in a transaction dated Tuesday, October 1st. The shares were sold at an average price of $400.07, for a total value of $18,928,911.98. Following the completion of the sale, the chief executive officer now owns 2,983,802 shares in the company, valued at approximately $1,193,729,666.14. This trade represents a 1.56 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CFO Brittany Bagley sold 4,338 shares of the business’s stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $378.95, for a total value of $1,643,885.10. Following the completion of the transaction, the chief financial officer now owns 98,825 shares in the company, valued at $37,449,733.75. The trade was a 4.20 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 137,921 shares of company stock worth $63,093,907. Corporate insiders own 6.10% of the company’s stock.

Analyst Ratings Changes

Several equities analysts have issued reports on AXON shares. Morgan Stanley raised Axon Enterprise from an “equal weight” rating to an “overweight” rating and boosted their price target for the company from $500.00 to $700.00 in a research note on Tuesday, December 3rd. Robert W. Baird boosted their target price on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research report on Friday. Needham & Company LLC raised their price target on shares of Axon Enterprise from $525.00 to $600.00 and gave the stock a “buy” rating in a report on Friday, November 8th. Northland Securities upped their price objective on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a report on Monday, November 11th. Finally, JMP Securities raised their target price on Axon Enterprise from $430.00 to $500.00 and gave the company a “market outperform” rating in a research note on Thursday, October 31st. One investment analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company. According to data from MarketBeat, Axon Enterprise presently has a consensus rating of “Moderate Buy” and an average target price of $488.67.

Axon Enterprise Stock Performance

Shares of Axon Enterprise stock opened at $687.69 on Friday. Axon Enterprise, Inc. has a 52 week low of $232.78 and a 52 week high of $698.67. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The business has a 50 day moving average price of $516.24 and a 200-day moving average price of $393.00. The company has a market cap of $52.44 billion, a PE ratio of 177.70, a price-to-earnings-growth ratio of 15.13 and a beta of 1.01.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.